{"id":4640,"date":"2020-09-15T13:50:31","date_gmt":"2020-09-15T13:50:31","guid":{"rendered":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/?p=4640"},"modified":"2020-09-15T14:01:48","modified_gmt":"2020-09-15T14:01:48","slug":"hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs","status":"publish","type":"post","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2020\/09\/15\/hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs\/","title":{"rendered":"Hallam research gives hope to developing new cancer-fighting drugs"},"content":{"rendered":"<p><b>Lucy Flint<\/b>, a final-year PhD student at the Biomolecular Sciences Research Centre (BMRC) at Hallam, has been working with AstraZeneca to\u00a0<a title=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.analchem.0c02389\" href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.analchem.0c02389\" data-cke-saved-href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.analchem.0c02389\" data-interception=\"on\">successfully characterise a 3D cell culture model<\/a>. It is hoped the research\u00a0findings can assist in the development of new anticancer drugs.\u00a0<i>Analytical Chemistry<\/i>, a scientific journal published by the American Chemical Society, will also be featuring the research on its upcoming front cover.<\/p>\n<p>We have been speaking to Lucy about her research project.<\/p>\n<div id=\"attachment_4641\" style=\"width: 306px\" class=\"wp-caption alignright\"><a href=\"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2020\/09\/15\/hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs\/dr-lucy-flint\/#main\" rel=\"attachment wp-att-4641\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-4641\" data-attachment-id=\"4641\" data-permalink=\"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2020\/09\/15\/hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs\/dr-lucy-flint\/#main\" data-orig-file=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?fit=400%2C400&amp;ssl=1\" data-orig-size=\"400,400\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Dr Lucy Flint\" data-image-description=\"\" data-image-caption=\"&lt;p&gt;Lucy Flint&lt;\/p&gt;\n\" data-large-file=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?fit=400%2C400&amp;ssl=1\" class=\"size-medium wp-image-4641\" src=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint-300x300.jpg?resize=300%2C300&#038;ssl=1\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?resize=300%2C300&amp;ssl=1 300w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?resize=150%2C150&amp;ssl=1 150w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?resize=144%2C144&amp;ssl=1 144w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?resize=50%2C50&amp;ssl=1 50w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Dr-Lucy-Flint.jpg?w=400&amp;ssl=1 400w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><p id=\"caption-attachment-4641\" class=\"wp-caption-text\">Lucy Flint<\/p><\/div>\n<p><b>\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b<\/b><b>How did your joint research project with AstraZeneca come about?<\/b><\/p>\n<p>There has been a long-standing collaboration between Sheffield Hallam and AstraZeneca through previous part-time PhD students who are employees at AstraZeneca and were supervised by\u00a0<strong>Professor\u00a0Malcolm Clench<\/strong>, including\u00a0<strong>Dr John Swales,<\/strong>\u00a0who completed his PhD in MS imaging in 2018.<\/p>\n<p><b>Can you tell us a little bit about what you were hoping to achieve?<\/b><\/p>\n<p>My visit to AstraZeneca was a brilliant opportunity for myself to work in an established research laboratory and experience industry. My aim was to learn and develop skills of experimental procedures and the use of high-performance imaging instrumentation available at AstraZeneca to apply these techniques for the analysis of my 3D cell culture models. It was also hoped that I could generate high-quality data that could be published. Through my first visit I was able to establish the basis of the formal collaboration agreement for my project between Sheffield Hallam and AstraZeneca, with the aim of exchanging knowledge on MS imaging and 3D cell culture.<\/p>\n<p><b>You mention\u00a0<i>3D cell culture\u00a0<\/i>\u2013 can you explain this to us?<\/b><\/p>\n<p>3D cell culture is an emerging method to study disease, helping to determine therapeutic targets in drug development. They are a product of a laboratory-created environment in which cells grow and interact with each other and their surroundings in three dimensions. This allows the cells to mimic the biological microenvironment of human tissues, promoting cell-cell interactions and the expression of essential molecules. The purpose of using 3D cell culture in scientific experiments is to create a realistic environment for drug testing whilst addressing the 3Rs principle, which is the reduction, replacement, and refinement of the use of animals in such research.<\/p>\n<p><b>How did your own skills and experience help make the project a success?<\/b><\/p>\n<p>I had been working on my PhD for 18 months prior to my first visit to AstraZeneca. During that time, I had developed my 3D cell culture models and practice MS imaging. Because of my experience of MS imaging, after instrument-specific training I was then able to carry out most of the experimental and analysis work independently at AstraZeneca. From the collaboration I was also able to bring my experimental skills and background of imaging 3D cell culture and specific MSI protocols for viewing peptides to the research group.<\/p>\n<p><b>What<\/b>\u00a0<b>were the main challenges you faced?<\/b><\/p>\n<p>As I was using different instrumentation to analyse my 3D model, one of the main challenges was developing an experimental workflow for each method, considering the different sample preparation steps required for the appropriate technique. I further developed protocols that were originally established for animal or clinical tissues and optimised methods for my 3D lung tumour model. The next challenge was to actually mine through the large data sets from each technique, finding key molecules, their relevance to specific regions of the tissues and complementary links between the different data sets which took some time.<\/p>\n<div id=\"attachment_4645\" style=\"width: 232px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2020\/09\/15\/hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs\/analytical-chemistry\/#main\" rel=\"attachment wp-att-4645\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-4645\" data-attachment-id=\"4645\" data-permalink=\"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2020\/09\/15\/hallam-research-gives-hope-to-developing-new-cancer-fighting-drugs\/analytical-chemistry\/#main\" data-orig-file=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?fit=2456%2C3262&amp;ssl=1\" data-orig-size=\"2456,3262\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;wardsdesign.com&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;no spine minimum. full size. Editor: Nella  JEM: Esther\\rRTP: Erin Dalton&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;Analytical Chemistry&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Analytical Chemistry\" data-image-description=\"&lt;p&gt;Analytical Chemistry front cover&lt;\/p&gt;\n\" data-image-caption=\"&lt;p&gt;no spine minimum. full size. Editor: Nella  JEM: Esther&lt;br \/&gt;\nRTP: Erin Dalton&lt;\/p&gt;\n\" data-large-file=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?fit=700%2C930&amp;ssl=1\" class=\"wp-image-4645 size-medium\" src=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover-226x300.jpg?resize=226%2C300&#038;ssl=1\" alt=\"\" width=\"226\" height=\"300\" srcset=\"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?resize=226%2C300&amp;ssl=1 226w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?resize=768%2C1020&amp;ssl=1 768w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?resize=771%2C1024&amp;ssl=1 771w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?w=1400 1400w, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/ancham_v092i018_cover.jpg?w=2100 2100w\" sizes=\"auto, (max-width: 226px) 100vw, 226px\" \/><\/a><p id=\"caption-attachment-4645\" class=\"wp-caption-text\">Analytical Chemistry front cover<\/p><\/div>\n<p><b>Can you provide a summary of your findings?<\/b><\/p>\n<p>In this paper, we used MS imaging to characterise our novel 3D model of lung cancer. This was with the purpose of understanding how these molecules within the tumour behave for potential applications in cancer research and drug development. MS imaging is a technique in which we can visualise a variety of molecules within a tissue without the use of labels. By determining the spatial information of a molecule, such as if the molecule is localised to a specific area or distributed throughout, we can understand the biological functions and interactions within a tissue.<\/p>\n<p>We were able to show that the lung tumour model had a similar structure to a human solid tumour with three distinct regions. This is significant in terms of drug delivery because it is difficult to deliver drug to the inner region of a solid tumour, and the fact that our model replicates this shows that it is a useful tool for drug development.<\/p>\n<p><b>What is the next step for the project?<\/b><\/p>\n<p>Now that we have characterised the 3D lung tumour model, we want to demonstrate the capabilities of this method for drug development applications by studying biopharmaceutical effectiveness. We aim to utilise the techniques we have developed to detect and quantify a commercial anticancer drug, Cetuximab, within the 3D model and determine its effects.<\/p>\n<p><b>And finally, how did you feel about your research being recognised by\u00a0<i>Analytical Chemistry?<\/i><\/b><\/p>\n<p>It is a really great feeling!\u00a0<em>Analytical Chemistry<\/em>\u00a0is a well-established journal, so to have my work recognised by them is very exciting. I am extremely passionate about MS imaging and 3D cell culture, so I hope it will open up a lot of opportunities. Since my paper has been published, I have had a lot of interest and one of my images is going to be featured on the front cover of the journal issue. I really enjoyed doing the work and I am\u00a0proud of my paper, so it is an amazing feeling to see its success.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lucy Flint, a final-year PhD student at the Biomolecular Sciences Research Centre (BMRC) at Hallam, has been working with AstraZeneca to\u00a0successfully characterise a 3D cell culture model. It is hoped&hellip;<\/p>\n","protected":false},"author":3083,"featured_media":4642,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"wds_primary_category":0,"footnotes":"","jetpack_publicize_message":"Hallam research gives hope to developing new cancer-fighting drugs","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[10,104],"tags":[],"class_list":["post-4640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-projects","category-research"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2020\/09\/Anticancer-drug-article.jpg?fit=1028%2C624&ssl=1","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p8KEAX-1cQ","jetpack-related-posts":[{"id":4047,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2019\/10\/07\/sheffield-hallam-leads-parkrun-anniversary-research\/","url_meta":{"origin":4640,"position":0},"title":"Sheffield Hallam leads parkrun anniversary research","author":"Mark Greene","date":"October 7, 2019","format":false,"excerpt":"Hallam press release Research conducted by Sheffield Hallam University's Advanced Wellbeing Research Centre (AWRC) has found that volunteering can have a bigger impact on health and wellbeing than just running or walking. Commissioned by UK-based charity parkrun in celebration of their 15th anniversary on Saturday 5 October, the research found\u2026","rel":"","context":"In &quot;In the Headlines&quot;","block_context":{"text":"In the Headlines","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/news\/hwbheadlines\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/10\/AWRC-Volunteering.jpg?fit=1028%2C624&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/10\/AWRC-Volunteering.jpg?fit=1028%2C624&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/10\/AWRC-Volunteering.jpg?fit=1028%2C624&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/10\/AWRC-Volunteering.jpg?fit=1028%2C624&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3615,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2019\/07\/04\/sheffield-hallam-appetite-research-cluster-writing-retreat\/","url_meta":{"origin":4640,"position":1},"title":"Sheffield Hallam Appetite Research Cluster &#8211; writing retreat","author":"Mark Greene","date":"July 4, 2019","format":false,"excerpt":"SHARE (Sheffield Hallam Appetite REsearch cluster) is a newly formed CKIP-funded cluster of around 30 academics from a diverse range of disciplines across 3 faculties.\u00a0The cluster will be\u00a0undertaking research in appetite regulation, eating behaviour, appetite modulation, obesity, weight management and associated areas. A writing retreat has been arranged for\u00a0 Wednesday\u2026","rel":"","context":"In &quot;Events&quot;","block_context":{"text":"Events","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Writing-retreat.jpg?fit=1028%2C624&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Writing-retreat.jpg?fit=1028%2C624&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Writing-retreat.jpg?fit=1028%2C624&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Writing-retreat.jpg?fit=1028%2C624&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":788,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2017\/09\/29\/autism-research\/","url_meta":{"origin":4640,"position":2},"title":"Sheffield Hallam Autism Research Partnership (SHARP)","author":"Jane Gardner-Florence","date":"September 29, 2017","format":false,"excerpt":"Sheffield Hallam Autism Research Partnership (SHARP)\u00a0is a new group for all those studying and working at SHU, with an interest in autism. The aim is to set up a multidisciplinary network\u00a0to generate new research projects, working in partnership with the autism community and regional stakeholders (e.g. schools, local authorities). Our\u2026","rel":"","context":"In &quot;Research&quot;","block_context":{"text":"Research","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/news\/research\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/09\/autism2.jpg?fit=1028%2C768&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/09\/autism2.jpg?fit=1028%2C768&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/09\/autism2.jpg?fit=1028%2C768&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/09\/autism2.jpg?fit=1028%2C768&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3687,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2019\/07\/22\/sheffield-hallam-joins-northern-health-science-alliance\/","url_meta":{"origin":4640,"position":3},"title":"Sheffield Hallam joins Northern Health Science Alliance","author":"Mark Greene","date":"July 22, 2019","format":false,"excerpt":"SHU press release Sheffield Hallam University will collaborate with a select group of hospital trusts, universities and industry partners across the north as part of the Northern Health Science Alliance (NHSA). The University has signed up as an Associate Member of the NHSA alongside nine other leading northern universities, ten\u2026","rel":"","context":"In &quot;News&quot;","block_context":{"text":"News","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Sheffield-Hallam-joins-Northern-Health-Science-Alliance.jpg?fit=1028%2C624&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Sheffield-Hallam-joins-Northern-Health-Science-Alliance.jpg?fit=1028%2C624&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Sheffield-Hallam-joins-Northern-Health-Science-Alliance.jpg?fit=1028%2C624&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/07\/Sheffield-Hallam-joins-Northern-Health-Science-Alliance.jpg?fit=1028%2C624&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3122,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2019\/03\/05\/great-ormond-street-grant-for-hallam-project\/","url_meta":{"origin":4640,"position":4},"title":"Great Ormond Street grant for Hallam project","author":"Mark Greene","date":"March 5, 2019","format":false,"excerpt":"SHU press release Sheffield Hallam University\u2019s Dr Susan Campbell has been awarded a grant of more than \u00a3189,000 from Great Ormond Street Hospital Children\u2019s Charity, and Sparks, the children\u2019s medical research charity, to fund research into the advancement of treatment of Vanishing White Matter Disease (VWMD). The grant is part\u2026","rel":"","context":"In &quot;News&quot;","block_context":{"text":"News","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/03\/Great-Ormond-Street-grant-for-Hallam-project.jpg?fit=1028%2C624&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/03\/Great-Ormond-Street-grant-for-Hallam-project.jpg?fit=1028%2C624&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/03\/Great-Ormond-Street-grant-for-Hallam-project.jpg?fit=1028%2C624&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2019\/03\/Great-Ormond-Street-grant-for-Hallam-project.jpg?fit=1028%2C624&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":831,"url":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/2017\/10\/11\/fingerprint-technology\/","url_meta":{"origin":4640,"position":5},"title":"Pioneering fingerprint technology verified in court","author":"Jane Gardner-Florence","date":"October 11, 2017","format":false,"excerpt":"Dr Simona Francese from the Biomolecular Sciences Research Centre has been speaking about a ground-breaking fingerprint profiling method, developed at Hallam, which can provide an in-depth analysis of fingerprints at crime scenes. The technology has been on trial with West Yorkshire Police which saw it successfully implemented during an investigation\u2026","rel":"","context":"In &quot;In the Headlines&quot;","block_context":{"text":"In the Headlines","link":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/category\/news\/hwbheadlines\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/10\/fingerprinttre.jpg?fit=1028%2C768&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/10\/fingerprinttre.jpg?fit=1028%2C768&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/10\/fingerprinttre.jpg?fit=1028%2C768&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogs.shu.ac.uk\/hwbstaffnews\/files\/2017\/10\/fingerprinttre.jpg?fit=1028%2C768&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/posts\/4640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/users\/3083"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/comments?post=4640"}],"version-history":[{"count":4,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/posts\/4640\/revisions"}],"predecessor-version":[{"id":4647,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/posts\/4640\/revisions\/4647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/media\/4642"}],"wp:attachment":[{"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/media?parent=4640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/categories?post=4640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.shu.ac.uk\/hwbstaffnews\/wp-json\/wp\/v2\/tags?post=4640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}